Key points are not available for this paper at this time.
Design
Review
Fibrosis biomarkers warrant cautious interpretation amid dual roles; leaves open validated thresholds for prospective outcome trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: